Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.

Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.

It has been proposed that diverse anticancer drugs and radiation therapy may induce a mode of cell death with the characteristics of apoptosis. Since apoptosis is under the control of several oncogenes, we analyzed the expression of the protein encoded by the proto-oncogenes bcl-2 and p53. Furthermo...

Descrizione completa

Dettagli Bibliografici
Autori principali:	Gasparini, G, Bevilacqua, P, Bonoldi, E, Testolin, A, Galassi, A, Verderio, P, Boracchi, P, Guglielmi, R, Pezzella, F
Natura:	Journal article
Lingua:	English
Pubblicazione:	1995

Documenti analoghi

Efficacy and safety of low-dose celecoxib with chemoradiation in locally advanced head-and-neck squamous cell carcinoma
di: Rethinesh Kumar T, et al.
Pubblicazione: (2024-07-01)

Neoadjuvant Concurrent Chemoradiation for Curative Treatment of Penile Squamous Cell Carcinoma
di: Arpit Chhabra, et al.
Pubblicazione: (2014-01-01)

Assessment of Neutrophil-to-Lymphocyte Ratio as A Prognostic Marker in Locally Advanced Head and Neck Cancer Treated with Concomitant Chemoradiation
di: Targain Elisha Servorip, et al.
Pubblicazione: (2023-10-01)

Acquired resistance to immunotherapy and chemoradiation in MYC amplified head and neck cancer
di: Thomas F. Cyberski, et al.
Pubblicazione: (2024-05-01)

FRZB: a potential prognostic marker for head and neck squamous cell carcinoma
di: Yunshan Li, et al.
Pubblicazione: (2024-05-01)

Re-irradiation with concurrent pembrolizumab for local-regionally recurrent squamous cell carcinoma of the head and neck
di: Allen M. Chen, et al.
Pubblicazione: (2025-03-01)

Bladder preservation by neoadjuvant chemotherapy followed by concurrent chemoradiation for muscle-invasive bladder cancer
di: Dalia Elsayed, et al.
Pubblicazione: (2023-04-01)

Concurrent Chemoradiation in a Patient with Unresectable Cholangiocarcinoma
Pubblicazione: (2010-03-01)

Prognostic factors of head and neck cutaneous squamous cell carcinoma: a systematic review
di: Joshua Lubov, et al.
Pubblicazione: (2021-09-01)

Prognosis of Pneumonia in Head and Neck Squamous Cell Carcinoma Patients Who Received Concurrent Chemoradiotherapy
di: Tzu-Hsun Kao, et al.
Pubblicazione: (2024-07-01)

Definitive Chemoradiation with Concurrent Weekly Cisplatin in the Treatment of Esophageal Squamous Cell Carcinoma – A Simplistic Approach
di: Imtiaz Ahmed, et al.
Pubblicazione: (2021-05-01)

Anaemia prevalence and blood transfusion rates in patients receiving chemoradiation for head and neck cancer
di: Higgins, G, et al.
Pubblicazione: (2007)

Effects of definitive chemoradiation on circulating immunologic angiogenic cytokines in head and neck cancer patients
di: F. Stephen Hodi, et al.
Pubblicazione: (2016-06-01)

FAP Serves as a Prognostic Biomarker in Head and Neck Squamous Cell Carcinoma
di: Zhanpeng Liao, et al.
Pubblicazione: (2024-01-01)

Cancer Stem Cell Markers in Head and Neck Squamous Cell Carcinoma
di: Aidan G. Major, et al.
Pubblicazione: (2013-01-01)

Comparison of 3D confromal radiotherapy and intensity modulated radiotherapy with or without simultaneous integrated boost during concurrent chemoradiation for locally advanced head and neck cancers.
di: Michael T Spiotto, et al.
Pubblicazione: (2014-01-01)

Erratum: Prognostic Value of Routine Blood Markers in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Pubblicazione: (2024-08-01)

p16 and p53 can Serve as Prognostic Markers for Head and Neck Squamous Cell Carcinoma
di: Yue Wang, et al.
Pubblicazione: (2024-06-01)

Results of implementation of a program of individual support of chemoradiation therapy in patients with head and neck tumors
di: A. R. Gevorkov, et al.
Pubblicazione: (2021-01-01)

The impact of nutritional intervention on quality of life and outcomes in patients with head and neck cancers undergoing chemoradiation
di: Sara Cardellini, et al.
Pubblicazione: (2024-10-01)

Prognostic Significance and Therapeutic Potential of SERPINE1 in Head and Neck Squamous Cell Carcinoma
di: Changyu Zhu, et al.
Pubblicazione: (2025-01-01)

Achalasia Combined with Esophageal Cancer Treated by Concurrent Chemoradiation Therapy
Pubblicazione: (2009-12-01)

Study of the association of the known prognostic variables with EGFR expression in head and neck squamous cell carcinomas
di: Toyaja Jadhav, et al.
Pubblicazione: (2023-07-01)

An Investigation of the Prognostic Role of Genes Related to Lipid Metabolism in Head and Neck Squamous Cell Carcinoma
di: Ling Qian, et al.
Pubblicazione: (2023-01-01)

Head and Neck Squamous Cell Carcinoma: NT5E Could Be a Prognostic Biomarker
di: Yaoting Zhang, et al.
Pubblicazione: (2022-01-01)

Application of Stacked Ensemble Techniques in Head and Neck Squamous Cell Carcinoma Prognostic Feature Subsets
di: Damianus Owusu, et al.
Pubblicazione: (2024-01-01)

Comprehensive Landscape of Prognostic Significance and Immune Characteristics of Myosins in Squamous Cell Carcinoma of the Head and Neck
di: Yuying Zhu, et al.
Pubblicazione: (2022-01-01)

Identification of PANoptosis-related biomarkers and analysis of prognostic values in head and neck squamous cell carcinoma
di: Ping Yang, et al.
Pubblicazione: (2024-04-01)

Cutaneous Squamous Cell Carcinoma of the Head and Neck
di: Vivek V. Gurudutt, et al.
Pubblicazione: (2011-01-01)

Tumour Recurrence, Depth of Invasion, and Temple Location as Independent Prognostic Parameters of Lymph Node Metastases of Head and Neck Cutaneous Squamous Cell Carcinomas
di: Zuzana Horakova, et al.
Pubblicazione: (2024-01-01)

Treatment outcomes of radiotherapy with concurrent weekly cisplatin in older patients with locally advanced head and neck squamous cell carcinoma
di: Yusuke Uchinami, et al.
Pubblicazione: (2023-12-01)

Response of FDG avid pelvic bone marrow to concurrent chemoradiation for anal cancer
di: Robinson, M, et al.
Pubblicazione: (2019)

Exosomal microRNAs Targeting TP53 Gene as Promising Prognostic Markers for Head and Neck Squamous Cell Carcinoma
di: Vijayashree Priyadharsini Jayaseelan, et al.
Pubblicazione: (2022-12-01)

The expression of immune co-stimulators as a prognostic predictor of head and neck squamous cell carcinomas and oral squamous cell carcinomas
di: Shi-Rou Chang, et al.
Pubblicazione: (2024-07-01)

Neck management in metastatic cutaneous squamous cell carcinoma of the head and neck
di: Ning Xu, et al.
Pubblicazione: (2024-02-01)

Morphology, Volume, and Density Characteristics of the Parotid Glands before and after Chemoradiation Therapy in Patients with Head and Neck Tumors
di: Wellington Pereira dos Santos, et al.
Pubblicazione: (2020-01-01)

Local and Systemic Pathogenesis and Consequences of Regimen-Induced Inflammatory Responses in Patients with Head and Neck Cancer Receiving Chemoradiation
di: Elvio G. Russi, et al.
Pubblicazione: (2014-01-01)

Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
di: Gasparini, G, et al.
Pubblicazione: (1995)

Prognostic Factors of Liposarcoma in Head and Neck
di: Shuo DING, et al.
Pubblicazione: (2025-01-01)

Prognostic value of novel immune-related genomic biomarkers identified in head and neck squamous cell carcinoma
di: Yun Chen, et al.
Pubblicazione: (2020-10-01)